The approved branded nasal spray from ... Even before the FDA's action, pharmacies could sell naloxone without a prescription because officials in every state have allowed it.
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as ...
The U.S. Food and Drug Administration (FDA) has approved the opioid-antidote naloxone known by its brand name Narcan to be sold over the counter (OTC). The news comes as drug-overdose deaths have ...
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
The approved branded nasal spray from ... Even before the FDA's action, pharmacies could sell naloxone without a prescription because officials in every state have allowed it.
The approved branded nasal spray from ... Even before the FDA's action, pharmacies could sell naloxone without a prescription because officials in every state have allowed it.
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the first of its kind ...
The FDA approved a new nasal spray to reverse the effects of an opioid overdose. Ready why the application for this drug was ...
After a more than 4-year battle, Plymouth Meeting biotechnology firm Braeburn Inc. has received FDA approval for its opioid ...
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters ... on Monday approved Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses, expanding ...
